Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Linagliptin on active GLP-1 in renal impairment
2013-000364-28Phase 4Completed
- Sponsor
- Profil
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of linagliptin in type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), sponsored by Profil. Primary endpoint: Change in active GLP-1 concentrations. Started Apr 2013; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2013-000364-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000364-28.